APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gemcitabine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gemcitabine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchGemcitabine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gemcitabine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Gemcitabine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gemcitabine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gemcitabine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gemcitabine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gemcitabine include Hisun Pharma, Pude Pharma, Qilu Pharma, Novartis, Mylan, Jari Pharma, Hansoh Pharma, Yibantian Pharma and HPGC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gemcitabine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gemcitabine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gemcitabine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gemcitabine market size, projected growth trends, production technologies, key applications, and end-use industries.

Gemcitabine Segment by Company

Hisun Pharma

Pude Pharma

Qilu Pharma

Novartis

Mylan

Jari Pharma

Hansoh Pharma

Yibantian Pharma

HPGC

Salius Pharma

Lilly France

Actavis

Accord Healthcare

Gemcitabine Segment by Type

1g/Vial

200mg/Vial

Gemcitabine Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Gemcitabine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gemcitabine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gemcitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gemcitabine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gemcitabine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gemcitabine Industry Trends Table 2. Gemcitabine Industry Drivers Table 3. Gemcitabine Industry Opportunities and Challenges Table 4. Gemcitabine Industry Restraints Table 5. Global Gemcitabine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gemcitabine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gemcitabine Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Gemcitabine Sales Market Share by Manufacturers Table 9. Global Gemcitabine Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Gemcitabine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gemcitabine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gemcitabine Manufacturers, Product Type & Application Table 13. Global Gemcitabine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gemcitabine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1g/Vial Table 17. Major Manufacturers of 200mg/Vial Table 18. Global Gemcitabine Sales by Type 2021 VS 2025 VS 2032 (kg) Table 19. Global Gemcitabine Sales by Type (2021-2026) & (kg) Table 20. Global Gemcitabine Sales by Type (2027-2032) & (kg) Table 21. Global Gemcitabine Sales Market Share by Type (2021-2026) Table 22. Global Gemcitabine Sales Market Share by Type (2027-2032) Table 23. Global Gemcitabine Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 24. Global Gemcitabine Revenue by Type (2021-2026) & (kg) Table 25. Global Gemcitabine Revenue by Type (2027-2032) & (kg) Table 26. Global Gemcitabine Revenue Market Share by Type (2021-2026) Table 27. Global Gemcitabine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacies Table 29. Major Manufacturers of Online Pharmacies Table 30. Major Manufacturers of Retail Pharmacies Table 31. Global Gemcitabine Sales by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Gemcitabine Sales by Application (2021-2026) & (kg) Table 33. Global Gemcitabine Sales by Application (2027-2032) & (kg) Table 34. Global Gemcitabine Sales Market Share by Application (2021-2026) Table 35. Global Gemcitabine Sales Market Share by Application (2027-2032) Table 36. Global Gemcitabine Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 37. Global Gemcitabine Revenue by Application (2021-2026) & (kg) Table 38. Global Gemcitabine Revenue by Application (2027-2032) & (kg) Table 39. Global Gemcitabine Revenue Market Share by Application (2021-2026) Table 40. Global Gemcitabine Revenue Market Share by Application (2027-2032) Table 41. Global Gemcitabine Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Gemcitabine Sales by Region (2021-2026) & (kg) Table 43. Global Gemcitabine Sales Market Share by Region (2021-2026) Table 44. Global Gemcitabine Sales Forecasted by Region (2027-2032) & (kg) Table 45. Global Gemcitabine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 47. North America Gemcitabine Sales by Country (2021-2026) & (kg) Table 48. North America Gemcitabine Sales by Country (2027-2032) & (kg) Table 49. Europe Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 50. Europe Gemcitabine Sales by Country (2021-2026) & (kg) Table 51. Europe Gemcitabine Sales by Country (2027-2032) & (kg) Table 52. Asia Pacific Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 53. Asia Pacific Gemcitabine Sales by Country (2021-2026) & (kg) Table 54. Asia Pacific Gemcitabine Sales by Country (2027-2032) & (kg) Table 55. South America, Middle East and Africa Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 56. South America, Middle East and Africa Gemcitabine Sales by Country (2021-2026) & (kg) Table 57. South America, Middle East and Africa Gemcitabine Sales by Country (2027-2032) & (kg) Table 58. Global Gemcitabine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Gemcitabine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Gemcitabine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Gemcitabine Revenue Market Share by Region (2021-2026) Table 62. Global Gemcitabine Revenue Market Share by Region (2027-2032) Table 63. Hisun Pharma Company Information Table 64. Hisun Pharma Business Overview Table 65. Hisun Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Hisun Pharma Gemcitabine Product Portfolio Table 67. Hisun Pharma Recent Development Table 68. Pude Pharma Company Information Table 69. Pude Pharma Business Overview Table 70. Pude Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pude Pharma Gemcitabine Product Portfolio Table 72. Pude Pharma Recent Development Table 73. Qilu Pharma Company Information Table 74. Qilu Pharma Business Overview Table 75. Qilu Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Pharma Gemcitabine Product Portfolio Table 77. Qilu Pharma Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Gemcitabine Product Portfolio Table 82. Novartis Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mylan Gemcitabine Product Portfolio Table 87. Mylan Recent Development Table 88. Jari Pharma Company Information Table 89. Jari Pharma Business Overview Table 90. Jari Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jari Pharma Gemcitabine Product Portfolio Table 92. Jari Pharma Recent Development Table 93. Hansoh Pharma Company Information Table 94. Hansoh Pharma Business Overview Table 95. Hansoh Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hansoh Pharma Gemcitabine Product Portfolio Table 97. Hansoh Pharma Recent Development Table 98. Yibantian Pharma Company Information Table 99. Yibantian Pharma Business Overview Table 100. Yibantian Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Yibantian Pharma Gemcitabine Product Portfolio Table 102. Yibantian Pharma Recent Development Table 103. HPGC Company Information Table 104. HPGC Business Overview Table 105. HPGC Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. HPGC Gemcitabine Product Portfolio Table 107. HPGC Recent Development Table 108. Salius Pharma Company Information Table 109. Salius Pharma Business Overview Table 110. Salius Pharma Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Salius Pharma Gemcitabine Product Portfolio Table 112. Salius Pharma Recent Development Table 113. Lilly France Company Information Table 114. Lilly France Business Overview Table 115. Lilly France Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Lilly France Gemcitabine Product Portfolio Table 117. Lilly France Recent Development Table 118. Actavis Company Information Table 119. Actavis Business Overview Table 120. Actavis Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Actavis Gemcitabine Product Portfolio Table 122. Actavis Recent Development Table 123. Accord Healthcare Company Information Table 124. Accord Healthcare Business Overview Table 125. Accord Healthcare Gemcitabine Sales (kg), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Accord Healthcare Gemcitabine Product Portfolio Table 127. Accord Healthcare Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Gemcitabine Distributors List Table 131. Gemcitabine Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Gemcitabine Product Image Figure 2. Global Gemcitabine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gemcitabine Market Size (2021-2032) & (US$ Million) Figure 4. Global Gemcitabine Sales (2021-2032) & (kg) Figure 5. Global Gemcitabine Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Gemcitabine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1g/Vial Image Figure 9. 200mg/Vial Image Figure 10. Global Gemcitabine Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 11. Global Gemcitabine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gemcitabine Sales Market Share by Type (2021-2032) Figure 13. Global Gemcitabine Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 14. Global Gemcitabine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gemcitabine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Online Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Global Gemcitabine Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Gemcitabine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gemcitabine Sales Market Share by Application (2021-2032) Figure 22. Global Gemcitabine Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global Gemcitabine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gemcitabine Revenue Market Share by Application (2021-2032) Figure 25. North America Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 26. North America Gemcitabine Sales Market Share by Country (2021-2032) Figure 27. U.S. Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 28. Canada Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 29. Mexico Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 30. Europe Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 31. Europe Gemcitabine Sales Market Share by Country (2021-2032) Figure 32. Germany Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 33. France Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 34. U.K. Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 35. Italy Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 36. Netherlands Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 37. Asia Pacific Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 38. Asia Pacific Gemcitabine Sales Market Share by Country (2021-2032) Figure 39. China Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 40. Japan Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 41. South Korea Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 42. Southeast Asia Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 43. India Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 44. Australia Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 45. South America, Middle East and Africa Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 46. South America, Middle East and Africa Gemcitabine Sales Market Share by Country (2021-2032) Figure 47. Brazil Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 48. South Africa Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 49. Saudi Arabia Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 50. Turkey Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 51. Argentina Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 52. UAE Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 53. Egypt Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 54. Chile Gemcitabine Sales and Growth Rate (2021-2032) & (kg) Figure 55. Global Gemcitabine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Gemcitabine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Gemcitabine Revenue (2021-2032) & (US$ Million) Figure 58. North America Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Gemcitabine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Gemcitabine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Gemcitabine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gemcitabine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Gemcitabine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1g/Vial
  • 200mg/Vial
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Hisun Pharma
  • Pude Pharma
  • Qilu Pharma
  • Novartis
  • Mylan
  • Jari Pharma
  • Hansoh Pharma
  • Yibantian Pharma
  • HPGC
  • Salius Pharma
  • Lilly France
  • Actavis
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gemcitabine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gemcitabine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gemcitabine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gemcitabine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gemcitabine Market Dynamics
  1. 2.1 Gemcitabine Industry Trends
  2. 2.2 Gemcitabine Industry Drivers
  3. 2.3 Gemcitabine Industry Opportunities and Challenges
  4. 2.4 Gemcitabine Industry Restraints
3 Gemcitabine Market by Manufacturers
  1. 3.1 Global Gemcitabine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gemcitabine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gemcitabine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gemcitabine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gemcitabine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gemcitabine Manufacturers, Product Type & Application
  7. 3.7 Global Gemcitabine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gemcitabine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gemcitabine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gemcitabine Tier 1, Tier 2, and Tier 3
4 Gemcitabine Market by Type
  1. 4.1 Gemcitabine Type Introduction
  2. 4.1.1 1g/Vial
  3. 4.1.2 200mg/Vial
  4. 4.2 Global Gemcitabine Sales by Type
  5. 4.2.1 Global Gemcitabine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gemcitabine Sales by Type (2021-2032)
  7. 4.2.3 Global Gemcitabine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gemcitabine Revenue by Type
  9. 4.3.1 Global Gemcitabine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gemcitabine Revenue by Type (2021-2032)
  11. 4.3.3 Global Gemcitabine Revenue Market Share by Type (2021-2032)
5 Gemcitabine Market by Application
  1. 5.1 Gemcitabine Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Gemcitabine Sales by Application
  6. 5.2.1 Global Gemcitabine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gemcitabine Sales by Application (2021-2032)
  8. 5.2.3 Global Gemcitabine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gemcitabine Revenue by Application
  10. 5.3.1 Global Gemcitabine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gemcitabine Revenue by Application (2021-2032)
  12. 5.3.3 Global Gemcitabine Revenue Market Share by Application (2021-2032)
6 Global Gemcitabine Sales by Region
  1. 6.1 Global Gemcitabine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gemcitabine Sales by Region (2021-2032)
  3. 6.2.1 Global Gemcitabine Sales by Region (2021-2026)
  4. 6.2.2 Global Gemcitabine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gemcitabine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gemcitabine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gemcitabine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gemcitabine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gemcitabine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gemcitabine Revenue by Region
  1. 7.1 Global Gemcitabine Revenue by Region
  2. 7.1.1 Global Gemcitabine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gemcitabine Revenue by Region (2021-2026)
  4. 7.1.3 Global Gemcitabine Revenue by Region (2027-2032)
  5. 7.1.4 Global Gemcitabine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gemcitabine Revenue (2021-2032)
  8. 7.2.2 North America Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gemcitabine Revenue (2021-2032)
  11. 7.3.2 Europe Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gemcitabine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gemcitabine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gemcitabine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hisun Pharma
  2. 8.1.1 Hisun Pharma Company Information
  3. 8.1.2 Hisun Pharma Business Overview
  4. 8.1.3 Hisun Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hisun Pharma Gemcitabine Product Portfolio
  6. 8.1.5 Hisun Pharma Recent Developments
  7. 8.2 Pude Pharma
  8. 8.2.1 Pude Pharma Company Information
  9. 8.2.2 Pude Pharma Business Overview
  10. 8.2.3 Pude Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pude Pharma Gemcitabine Product Portfolio
  12. 8.2.5 Pude Pharma Recent Developments
  13. 8.3 Qilu Pharma
  14. 8.3.1 Qilu Pharma Company Information
  15. 8.3.2 Qilu Pharma Business Overview
  16. 8.3.3 Qilu Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharma Gemcitabine Product Portfolio
  18. 8.3.5 Qilu Pharma Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Gemcitabine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Gemcitabine Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Jari Pharma
  32. 8.6.1 Jari Pharma Company Information
  33. 8.6.2 Jari Pharma Business Overview
  34. 8.6.3 Jari Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jari Pharma Gemcitabine Product Portfolio
  36. 8.6.5 Jari Pharma Recent Developments
  37. 8.7 Hansoh Pharma
  38. 8.7.1 Hansoh Pharma Company Information
  39. 8.7.2 Hansoh Pharma Business Overview
  40. 8.7.3 Hansoh Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hansoh Pharma Gemcitabine Product Portfolio
  42. 8.7.5 Hansoh Pharma Recent Developments
  43. 8.8 Yibantian Pharma
  44. 8.8.1 Yibantian Pharma Company Information
  45. 8.8.2 Yibantian Pharma Business Overview
  46. 8.8.3 Yibantian Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yibantian Pharma Gemcitabine Product Portfolio
  48. 8.8.5 Yibantian Pharma Recent Developments
  49. 8.9 HPGC
  50. 8.9.1 HPGC Company Information
  51. 8.9.2 HPGC Business Overview
  52. 8.9.3 HPGC Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HPGC Gemcitabine Product Portfolio
  54. 8.9.5 HPGC Recent Developments
  55. 8.10 Salius Pharma
  56. 8.10.1 Salius Pharma Company Information
  57. 8.10.2 Salius Pharma Business Overview
  58. 8.10.3 Salius Pharma Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Salius Pharma Gemcitabine Product Portfolio
  60. 8.10.5 Salius Pharma Recent Developments
  61. 8.11 Lilly France
  62. 8.11.1 Lilly France Company Information
  63. 8.11.2 Lilly France Business Overview
  64. 8.11.3 Lilly France Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lilly France Gemcitabine Product Portfolio
  66. 8.11.5 Lilly France Recent Developments
  67. 8.12 Actavis
  68. 8.12.1 Actavis Company Information
  69. 8.12.2 Actavis Business Overview
  70. 8.12.3 Actavis Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Actavis Gemcitabine Product Portfolio
  72. 8.12.5 Actavis Recent Developments
  73. 8.13 Accord Healthcare
  74. 8.13.1 Accord Healthcare Company Information
  75. 8.13.2 Accord Healthcare Business Overview
  76. 8.13.3 Accord Healthcare Gemcitabine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Accord Healthcare Gemcitabine Product Portfolio
  78. 8.13.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gemcitabine Value Chain Analysis
  2. 9.1.1 Gemcitabine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gemcitabine Production Mode & Process
  6. 9.2 Gemcitabine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gemcitabine Distributors
  9. 9.2.3 Gemcitabine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst